102 related articles for article (PubMed ID: 27834032)
1. Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
Kitahara T; Haraguchi N; Takahashi H; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Ann Surg Oncol; 2017 Apr; 24(4):1110-1119. PubMed ID: 27834032
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
Huang R; Wang G; Song Y; Tang Q; You Q; Liu Z; Chen Y; Zhang Q; Li J; Muhammand S; Wang X
Mol Med Rep; 2015 Aug; 12(2):2417-24. PubMed ID: 25936357
[TBL] [Abstract][Full Text] [Related]
3. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
4. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
5. Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin.
Lin YM; Chen CI; Hsiang YP; Hsu YC; Cheng KC; Chien PH; Pan HL; Lu CC; Chen YJ
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899208
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.
Moon HH; Kim SH; Ku JL
Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773
[TBL] [Abstract][Full Text] [Related]
7. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
8. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
[TBL] [Abstract][Full Text] [Related]
9. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
Plasencia C; Abad A; Martinez-Balibrea E; Taron M
Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
[TBL] [Abstract][Full Text] [Related]
11. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
13. Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
Ju HQ; Lu YX; Wu QN; Liu J; Zeng ZL; Mo HY; Chen Y; Tian T; Wang Y; Kang TB; Xie D; Zeng MS; Huang P; Xu RH
Oncogene; 2017 Nov; 36(45):6282-6292. PubMed ID: 28692052
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity.
Munakata K; Uemura M; Tanaka S; Kawai K; Kitahara T; Miyo M; Kano Y; Nishikawa S; Fukusumi T; Takahashi Y; Hata T; Nishimura J; Takemasa I; Mizushima T; Ikenaga M; Kato T; Murata K; Carethers JM; Yamamoto H; Doki Y; Mori M
Clin Cancer Res; 2016 Nov; 22(21):5277-5286. PubMed ID: 27166395
[TBL] [Abstract][Full Text] [Related]
15. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
Miyaki Y; Suzuki K; Koizumi K; Kato T; Saito M; Kamiyama H; Maeda T; Shibata K; Shiya N; Konishi F
Int J Oncol; 2012 Jan; 40(1):217-26. PubMed ID: 21901246
[TBL] [Abstract][Full Text] [Related]
16. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.
Jensen NF; Stenvang J; Beck MK; Hanáková B; Belling KC; Do KN; Viuff B; Nygård SB; Gupta R; Rasmussen MH; Tarpgaard LS; Hansen TP; Budinská E; Pfeiffer P; Bosman F; Tejpar S; Roth A; Delorenzi M; Andersen CL; Rømer MU; Brünner N; Moreira JM
Mol Oncol; 2015 Jun; 9(6):1169-85. PubMed ID: 25759163
[TBL] [Abstract][Full Text] [Related]
18. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity.
Druzhkova I; Ignatova N; Prodanets N; Kiselev N; Zhukov I; Shirmanova M; Zagainov V; Zagaynova E
Clin Colorectal Cancer; 2019 Mar; 18(1):e74-e86. PubMed ID: 30415989
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.
Zhang YJ; Li AJ; Han Y; Yin L; Lin MB
World J Gastroenterol; 2014 Jul; 20(25):8229-36. PubMed ID: 25009397
[TBL] [Abstract][Full Text] [Related]
20. A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.
Allen WL; Stevenson L; Coyle VM; Jithesh PV; Proutski I; Carson G; Gordon MA; Lenz HJ; Van Schaeybroeck S; Longley DB; Johnston PG
Mol Cancer Ther; 2012 Jan; 11(1):119-31. PubMed ID: 22027693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
